The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Maksimenko A.V.

Institute of the Clinical Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, Moscow, Russia

Approximation of new generation pharmacological enzyme researches to clinical practice

Authors:

Maksimenko A.V.

More about the authors

Journal: Russian Cardiology Bulletin. 2018;13(4): 41‑49

Read: 1630 times


To cite this article:

Maksimenko AV. Approximation of new generation pharmacological enzyme researches to clinical practice. Russian Cardiology Bulletin. 2018;13(4):41‑49. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20181304141

Recommended articles:
Oxidative stress and antioxidant protection in diso­rders of cere­bral circulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):114-119
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Sleep deprivation and the deve­lopment of oxidative stress in animal models. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):124-129
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14

References:

  1. Chazov EI, Smirnov VN, Torchilin VP. Drug targeting delivery: problems and perspectives. Zhurnal D.I. Mendeleev Vsesojuzn chem society. 1987;XXXII(5):485-487. (In Russ.)
  2. Maksimenko AV, Tischenko EG. New thrombolytic strategy: bolus admiÂnistration of tPA and urokinase-fibrinogen conjugate. Journal of Thrombosis and Thrombolysis. 1999;7(3):307-312. https://doi.org/10.1023/A:1008939428688
  3. Maksimenko AV. Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase. Current Pharmaceutical Design. 2005;11(16):2007-2016. https://doi.org/10.2174/1381612054065756
  4. Maksimenko AV. Development and application of targeted therapeutic protein conjugates. Russian Journal of General Chemistry. 2014;84(2):357-363. https://doi.org/10.1134/S1070363214020376
  5. Van Geel R, Wijdeven MA, Heesbeen R, Verkade JM, Wasiel AA, van Berkel SS, van Delft FL. Chemoenzymatic conjugation of toxic payloads to the globally conserved N-glycan of native mAbs provides homogenous and highly efficacious antibody-drug conjugates. Bioconjugate Chemistry. 2015;26(11):233-2242. https://doi.org/10.1021/acs.bioconjchem.5b00224
  6. Ong GL, Ettenson D, Sharkey RM, Marks A, Baumal R, Goldenberg DM, Matters MJ. Galactose-conjugated antibodies in cancer therapy: properties and principles of action. Cancer Research. 1991;51(6):1619-1626.
  7. Nakamura S, Kato A. Multi-functional biopolymer prepared by covalent attachment of galactomannan to egg-whight proteins through naturally occurring Maillard reaction. Die Nahrung. 2000;44(3):201-206. https://doi.org/10.1002/15213803(20000501)44:<201::AID-FOOD201>3.0.CO;2-S
  8. Wang L, Yuan L, Wang H, Liu X, Li X, Chen H. New strategy for reversible modulation of protein activity through site-specific conjugation of small molecule and polymer. Bioconjugate Chemistry. 2014;25(7):1252-1260. https://doi.org/10.1021/bc5000934
  9. Soucek J, Pouchkova P, Gtrohalm J, Plocova D, Hlouskova D, Zadinova M, Ulbrich K. Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice. Journal of Drug Targeting. 2002;10(3):175-183. https://doi.org/10.1080/10611860290022606
  10. Harris J, Jacobson F, Jocheim C, Amphlett G, Francissen K, McLeod L. Uniting small-molecule and biologic drug perspectives: analytical characterization and regulatory consideration for antibody-drug conjugates. BioProcess International. 2015;13(8):4-14.
  11. Wooge C. Process challenges of antibody-drug conjugates. BioProcess International. 2014;12(suppl 3):28-31.
  12. Howard CB, Fletcher N, Honston ZH, Fuchs AV, Boase NR, Simpson JD, Raftery LJ, Ruder T, Jones ML, de Bakker CJ, Mahler SM, Thurecht KJ. Overcomong instability of antibody-nanomaterial conjugates: next generation targeted nanomedicines using bispecific antibodies. Advanced Healthcare Materials. 2016;5(16):2055-2068. https://doi.org/10.1002/adhm.201600263
  13. Freitas DS, Abrahao-Neto J. Biochemical and biophysical characterization of lysozyme modified by PEGylation. International Journal of Pharmaceutics. 2010;393(1-2):111-117. https://doi.org/10.1016/j.ijpharm.2010.03.036
  14. Kultti A, Zhao C, Singha NC, Zimmerman S, Osgood RJ, Symons R, Jiang P, Li X, Thompson CB, Infante JR, Jacobetz MA, Tuveson DA, Frost GI, Shepard HM, Huang Z. Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. BioMed Research International. 2014; Article ID 817613. https://doi.org/10.1115/2014/817613
  15. Mero A, Schiavon M, Veronese FM, Pasut G. A new method to increaseselectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone. Journal of Controlled Release. 2011;154(1):27-34. https://doi.org/10.1016/j.jconrel.2011.04.024
  16. Kejik Z, Briza T, Kralova J, Pouchkova P, Kral A, Martasek P, Kral V. Coordination conjugates of therapeutic proteins with drug carriers: a new approach for versatile advanced drug delivery. Bioorganic and Medicinal CheÂmistry Letters. 2011;21(18):5514-5520. https://doi.org/10.1016/j.bmcl.2011.06.101
  17. Dilgimen AS, Mustafaeva Z, Demchenko M, Kaneko T, Osada Y, Mustafaev M. Water-soluble covalent conjugates of bovine serum albumin with anionic poly(N-isopropyl-acrylamide) and their immunogenicity. Biomaterials. 2001;22(17):2383-2392. https://doi.org/10.1016/S0142-9612(00)00425-7
  18. Zhang HW, Wang FS, Shao W, Zheng XL, Qi JZ, Cao JC, Zhang TM. CharaÂcterization and stability investigation of Cu,Zn-superoxide dismutase covalently modified by low molecular weight heparin. Biochemistry (Moscow). 2006;71(suppl 1):96-100. https://doi.org/10.1134/s0006297906130165
  19. Wu FL, Yeh TH, Chen YL, Chiu YC, Cheng JC, Wei MF, Shen LG. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Molecular Pharmaceutics. 2014;11(8):2777-2786. https://doi.org/10.1021/mp5001372
  20. Ashrafi H, Amini M, Mohammadi-Samani S, Ghasemi Y, Azadi A, Tabanden MR, Kamali-Sarvestani E, Daneshamouz S. Nanostructure L-asparaginase-fatty acid bioconjugate: synthesis, preformulation study and biological assessment. International Journal of Biological Macromolecules. 2013;62:180-187. https://doi.org/10.1016/j.biomac.2013.08.028
  21. Xie D, Yao C, Wang L, Min W, Xu J, Xiao J, Huang M, Chen M, Liu B, Li X, Jiang H. An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-life. Antimicrobial Agents and Chemotherapy. 2010;54(1):191-196. https://doi.org/10.1128/AAC.00976-09
  22. Maksimenko AV, Turashev AD, Bibilashvili RSh. Stratification of chondroitin sulfate binding sites in 3D-model of bovine testicular hyaluronidase and effective size of glycosaminoglycan coat of the modified protein. Biochemistry (Moscow). 2015;80(3):348-357. (In Russ.) https://doi.org/10.1134/S0006297915030049
  23. Maksimenko AV, Bibilashvili RSh. Conformational transitions in 3D-model of bovine testicular hyaluronidase during molecular docking with glycosaminoglycan ligands. J Bioorgan chemistry. 2018;44(2):165-172. (In Russ.) https://doi.org/10.1134/S1068162018020048
  24. Maksimenko AV, Vavaev AV. Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart International. 2012;7(1):14-19. https://doi.org/10.4081/hi2012.e3
  25. Siti HN, Kamisah Y, Kamsah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease. Vascular Pharmacology. 2015;71:40-56. https://doi.org/10.1016/j.vph.2015.03.005
  26. Münzel T, Gori T, Keaney JF., Jr, Maack C, Daiber A. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. European Heart Journal. 2015;36(38):2555-2564. https://doi.org/10.1093/eurheart/ehv305
  27. Brito R, Castillo G, Gonzalez J, Valls N, Rodrigo R. Oxidative stress in hypertension: mechanisms and therapeutic opportunities. Experimental and Clinical Endocrinology and Diabetes. 2015;123(6):325-335. https://doi.org/10.1055/s-0035-1548765
  28. Ekelof S, Jensen SE, Rosenberg J, Gögenur I. Reduced oxidative stress in STEMI patients treated by primary percutaneous coronary intervention and with antioxidant therapy: a systematic review. Cardiovascular Drugs and Therapy. 2014;28(2):173-181. https://doi.org/10.1016/j.bbrc.2007.06.054
  29. Lee S, Murthy N. Targeted delivery of catalase and superoxide dismutase to macrophages using folate. Biochemical and Biophysical Research Communications. 2007;360(1):275-279. https://doi.org/10.1016/j.bbrc.2007.06.054
  30. Mansuroglu B, Derman S, Yaba A, Kizilbey K. Protective effect of hemically modified SOD on lipid peroxidation and antioxidant status in diabetic rats. International Journal of Biological Macromolecules. 2015;72:79-87. https://doi.org/10.1016/j.ijbiomac.2014.07.039
  31. Lutton EM, Razmpour R, Andrews AM, Canella LA, Son YJ, Shuvaev VV, Muzykantov VR, Ramirez SH. Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury. Scientific Reports. 2017;7(1):3846-3860. https://doi.org/10.1038/s41598-017-03309-4
  32. Richard PU, Duskey JT, Stolarov S, Spulber M, Palivan CG. New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assembles. Expert Opinion on Drug Delivery. 2015;12(9):1527-1545. https://doi.org/10.1517/17425247.2015.1036738
  33. Sandhir R, Yadav A, Sunkaria A, Singhal N. Nano-antioxidants: an emerging strategy for intervention against neurodegenerative conditions. Neurochemistry International. 2015;89:209-226. https://doi.org/10.1016/j.neuint.2015.08.011
  34. Krotenko NM, Smirnova LP, Mednova IA, Sinyanskiy LE, Krotenko NR, Ivanova SA. Catalase and superoxide dismutase activity of abzymes in patients with multiple sclerosis. Acta Naturae. 2016;2:180. (In Russ.) https://www.ncbi.nlm.nih.gov/m/pubmed/
  35. Lyublinskaya OG, Smirnova IS, Pugovkina NA, Kornienko YuS, Zenin VV, Nikolsky NN. The response of human endometrial mesenchymal stem cells against antioxidant stress. Acta Naturae. 2016;2:51. (In Russ.) https://www.ncbi.nlm.nih.gov/m/pubmed/
  36. Hood ED, Chorny M, Greineder CF, Alferiev I, Levy RJ, Muzykantov VR. Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation. Biomaterials. 2014;35;(11):3708-3715. https://doi.org/10.1016/j.biomaterials.2014.01.023
  37. Kost OA, Beznos OV, Davydova NG, Manickam DS, Nikolskaya II, Guller AE, Binevski PV, Chesnokova NB, Shekhter AB, Klyachko NL, Kabanov AV. Superoxide dismutase 1 nanozyme for treatment of eye inflammation. Oxidative Medicine and Cellular Longevity. 2016;5194239. https://doi.org/10.1155/2016/5194239
  38. Maksimenko AV, Vavaev AV, Buryachkovskaya LI, Mokh VP, Uchitel IA, Lakomkin VL, Kapelko VI, Tishchenko EG. Biopharmacology of enzyme conjugates: vasoprotective activity of supramolecular superoxide dismutase-chondroitin sulfate-catalase derivative. Acta Naturae. 2010;2(4):90-103. (In Russ.)
  39. Maksimenko AV, Golubykh VL, Tischenko EG. The combination of modified antioxidant enzymes for anti-thrombotic protection of vascular wall: the significant of covalent connection of superoxide dismutase and catalase activities. The Journal of Pharmacy and Pharmacology. 2004;56(11):1463-1468. https://doi.org/10.1211/0022357044544
  40. Maksimenko AV. Widening and elaboration of consecutive research into therapeutic antioxidant enzyme derivatives. Oxidative Medicine and Cellular Longevity. 2016;2016:3075695. https://doi.org/10.1155/2016/3075695
  41. Rajput YS, Gupta MN. A conjugate of trypsin and chymotrypsin. Applied Biochemistry and Biotechnology. 1987;16:201-210. https://doi.org/10.1007/BF02798367
  42. Nazarian KB, Siminian SZ, Kazarian BA, Perez P, Climent F. Purification of enolase and phosphoglycerate mutase from human brain and formation of a bienzymatic complex from them. Biokhimiia. 1995;60(5):746-753. https://www.ncbi.nlm.nih.gov/m/pubmed/7662801
  43. Mao GD, Thomas PD, Lopaschuk GD, Poznansky MJ. Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. The Journal of Biological Chemistry. 1993;268(1):416-420. https://www.ncbi.nlm.nih.gov/m/pubmed/8380162
  44. Nadithe V, Bae YH. Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb-SOD-CAT) for protection from free radical stress. International Journal of Biological Macromolecules. 2010;47(5):603-613. https://doi.org/10.1016/j.ijbiomac.2010.08.007
  45. Luangwattananun P, Yamoy S, Eiamphungporn W, Sondtawee N, Bülow L, Ayudhya CI, Prachayasittikul V. Engineering of novel tri-functional enzyme with MnSOD, catalase and cell-permeable activities. International Journal of Biological Macromolecules. 2016;85:451-459. https://doi.org/10.1016/j.ijbiomac.2016.01.020
  46. Karaduleva EV, Mubarakshina EK, Sharapov MG, Volkova AE, Pimenov OY, Ravin VK, Kokoz YM, Novoselov VI. Cardioprotective effect of modified peroxiredoxins in retrograde perfusion of isolated rat heart under conditions of oxidative stress. Bulletin of Experimental Biology and Medicine. 2016;160(5):639-642. https://doi.org/10.1007/s0026893314040128
  47. Sharapov MG, Novoselov VI, Ravin VK. Construction of a fusion enzyme exhibiting superoxide dismutase and peroxidase activity. Biochemistry. 2016;81(4):571-579. (In Russ.) https://doi.org/10.1134/S0006297916040131
  48. Sharapov MG, Novoselov VI, Fesenko EE, Bruskov VI, Gudkov SV. The role of peroxiredoxin 6 in neutralization of X-ray mediated oxidative stress: effects on gene expression, preservation of radiosensitive tissue and postradiation survival of animals. Free Radical Research. 2017;51(2):148-166. https://doi.org/10.1080/10715762.2017.1289377
  49. Maksimenko AV. Cardiological biopharmaceuticals in the conception of drug targeting delivery: practical results and research perspectives. Acta Naturae. 2012;4(3):76-86. (In Russ.)
  50. Maksimenko AV. Molecular aspects cardiology in vascular wall research. Kardiologija. 2017;57(7):66-79. (In Russ.) https://doi.org/10.18087/cardio.2017.7.10008

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.